Westlake Chemical Partners (WLKP) Common Equity (2013 - 2026)

Westlake Chemical Partners has reported Common Equity for 14 years, with the latest figure at $792.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 1.33% year-over-year to $792.4 million; the trailing twelve-month figure through Mar 2026 stood at $792.4 million (down 1.33% YoY), and the FY2025 full-year result was $802.4 million, down 3.25% from the prior year.
• Common Equity for Q1 2026 stood at $792.4 million, down from $802.4 million in the prior quarter.
• The five-year high for Common Equity was $976.2 million in Q1 2022, with the low at $792.4 million in Q1 2026.
• Historically, Common Equity has averaged $862.9 million across 5 years, with a median of $848.2 million in 2024.
• Annual changes were most pronounced in 2022 — Common Equity increased 6.91% — and 2023, when it dropped 10.42%.
• Westlake Chemical Partners' Common Equity stood at $903.7 million in 2022, then slipped by 5.25% to $856.2 million in 2023, then fell by 3.15% to $829.3 million in 2024, then decreased by 3.25% to $802.4 million in 2025, then slipped by 1.24% to $792.4 million in 2026.
• The last three Common Equity figures came in at $792.4 million (Q1 2026), $802.4 million (Q4 2025), and $813.3 million (Q3 2025), per Business Quant data.